Literature DB >> 14600431

No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.

Tevfik Ecder1, Kimberly K McFann, Mary V Raynolds, Robert W Schrier.   

Abstract

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) shows a variable clinical course suggesting that genetic modifiers might play a role. There are conflicting results about the effect of angiotensin-converting enzyme (ACE) gene polymorphism on the progression of renal failure in ADPKD. Also, the association between ACE gene polymorphism and the occurrence of left ventricular hypertrophy (LVH) has not been investigated in patients with ADPKD.
METHODS: ACE genotype analysis was performed in 409 Caucasian patients (137 male, 272 female) with ADPKD. Echocardiographic examination was done in 164 of these patients.
RESULTS: There were no significant differences between different ACE genotypes regarding renal function, renal volume, urinary protein excretion, blood pressure, the rate of hypertension, the age at diagnosis of hypertension, the rate of LVH and the incidence of end-stage renal disease (ESRD).
CONCLUSION: ACE gene polymorphism does not have a significant effect on the development of ESRD and the prevalence of LVH in patients with ADPKD. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600431     DOI: 10.1159/000074653

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  3 in total

1.  Endothelial nitric oxide synthase gene expression is associated with hypertension in autosomal dominant polycystic kidney disease.

Authors:  Ismail Kocyigit; Serpil Taheri; Elif Funda Sener; Aydin Unal; Eray Eroglu; Fahir Öztürk; Kezban Korkmaz; Gokmen Zararsiz; Hakan Imamoglu; Murat Hayri Sipahioglu; Bulent Tokgoz; Oktay Oymak
Journal:  Cardiorenal Med       Date:  2014-12-10       Impact factor: 2.041

Review 2.  Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Authors:  Tevfik Ecder; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

3.  High prevalence of ACE DD genotype among north Indian end stage renal disease patients.

Authors:  Gaurav Tripathi; Poonam Dharmani; Faisal Khan; R K Sharma; Vinod Pandirikkal; Suraksha Agrawal
Journal:  BMC Nephrol       Date:  2006-10-17       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.